Clinical trial
The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
NCT03679780 is registered in ClinicalTrials.gov with The University of Texas at Arlington as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Endothelin and L-Arginine on Racial Differences in Vasoconstriction
- Lead sponsor
- The University of Texas at Arlington
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- July 26, 2023
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiovascular diseases, cardiovascular risk factor, vasoconstriction